184 related articles for article (PubMed ID: 15068388)
1. Polymorphisms of tumor necrosis factor and myeloperoxidase genes in patients with chronic renal failure on peritoneal dialysis.
Buraczynska K; Koziol-Montewka M; Majdan M; Ksiazek A
Mol Diagn; 2003; 7(3-4):175-80. PubMed ID: 15068388
[TBL] [Abstract][Full Text] [Related]
2. Genetic determination of TNF and myeloperoxidase production in dialyzed patients with diabetic nephropathy.
Buraczynska K; Koziol-Montewka M; Majdan M; Tokarz A; Ksiazek A
Ren Fail; 2004 Nov; 26(6):633-9. PubMed ID: 15600254
[TBL] [Abstract][Full Text] [Related]
3. Association of tumour necrosis factor-α polymorphism in patients with end stage renal disease.
Singh K; Prasad KN; Mishra P; Singh SK; Kharwar NK; Prasad N; Gupta A; Srivastava JK
Nephrology (Carlton); 2015 Jun; 20(6):387-91. PubMed ID: 25589331
[TBL] [Abstract][Full Text] [Related]
4. Cytokine gene polymorphisms in hemodialysis patients: association with comorbidity, functionality, and serum albumin.
Balakrishnan VS; Guo D; Rao M; Jaber BL; Tighiouart H; Freeman RL; Huang C; King AJ; Pereira BJ;
Kidney Int; 2004 Apr; 65(4):1449-60. PubMed ID: 15086488
[TBL] [Abstract][Full Text] [Related]
5. Functional polymorphism of the myeloperoxidase gene in hypertensive nephrosclerosis dialysis patients.
Doi K; Noiri E; Maeda R; Nakao A; Kobayashi S; Tokunaga K; Fujita T
Hypertens Res; 2007 Dec; 30(12):1193-8. PubMed ID: 18344624
[TBL] [Abstract][Full Text] [Related]
6. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
Manchanda PK; Kumar A; Kaul A; Mittal RD
Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
[TBL] [Abstract][Full Text] [Related]
7. Association between interleukin-10 gene polymorphism -592 (A/C) and peritoneal transport in patients undergoing peritoneal dialysis.
Lee YT; Tsai YC; Yang YK; Hsu KT; Liao SC; Wu CH; Cheng BC; Chen JB; Lee CH; Lee CT
Nephrology (Carlton); 2011 Sep; 16(7):663-71. PubMed ID: 21777343
[TBL] [Abstract][Full Text] [Related]
8. Tumor necrosis factor-alpha gene polymorphism correlates with cardiovascular disease in patients with end-stage renal disease.
Buraczynska M; Mierzicki P; Buraczynska K; Dragan M; Ksiazek A
Mol Diagn Ther; 2007; 11(4):257-63. PubMed ID: 17705580
[TBL] [Abstract][Full Text] [Related]
9. A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.
Pecoits-Filho R; Stenvinkel P; Marchlewska A; Heimburger O; Bárány P; Hoff CM; Holmes CJ; Suliman M; Lindholm B; Schalling M; Nordfors L
Kidney Int Suppl; 2003 May; (84):S172-6. PubMed ID: 12694338
[TBL] [Abstract][Full Text] [Related]
10. [Association of the tumor necrosis factor-alpha -1031T/C and its combination with interleukin-6 -634C/G gene polymorphisms with susceptibility to endometriosis].
Mao T; Zong LL; Wang YF; Zeng J; Fu YG; Zhao X; Rao XQ; Huang YX; Xu ZM; Zhu XN
Zhonghua Fu Chan Ke Za Zhi; 2012 May; 47(5):328-32. PubMed ID: 22883518
[TBL] [Abstract][Full Text] [Related]
11. Early failure of dental implants and TNF-alpha (G-308A) gene polymorphism.
Campos MI; dos Santos MC; Trevilatto PC; Scarel-Caminaga RM; Bezerra FJ; Line SR
Implant Dent; 2004 Mar; 13(1):95-101. PubMed ID: 15017311
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of the association between chronic hepatitis B and C infections and TNF-α (-308) gene polymorphism].
Börekçi G; Aras N; Kandemir Ö; Yalın S; Karakaş Çelik S; Berköz M
Mikrobiyol Bul; 2016 Apr; 50(2):236-44. PubMed ID: 27175496
[TBL] [Abstract][Full Text] [Related]
13. A - 308 promoter polymorphism of tumor necrosis factor alpha gene does not associate with the susceptibility to psoriasis vulgaris. No difference either between psoriasis type I and type II patients.
Baran W; Szepietowski JC; Mazur G; Baran E
Acta Dermatovenerol Alp Pannonica Adriat; 2006 Sep; 15(3):113-8. PubMed ID: 17053845
[TBL] [Abstract][Full Text] [Related]
14. Role of non-HLA genetic variants in end-stage renal disease.
Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: association with susceptibility and clinical manifestations.
El-Shabrawi Y; Wegscheider BJ; Weger M; Renner W; Posch U; Ulrich S; Ardjomand N; Hermann J
Ophthalmology; 2006 Apr; 113(4):695-700. PubMed ID: 16581430
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma polymorphisms affect systemic inflammation and survival in end-stage renal disease patients starting renal replacement therapy.
Yao Q; Nordfors L; Axelsson J; Heimbürger O; Qureshi AR; Báràny P; Lindholm B; Lönnqvist F; Schalling M; Stenvinkel P
Atherosclerosis; 2005 Sep; 182(1):105-11. PubMed ID: 16115480
[TBL] [Abstract][Full Text] [Related]
17. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor-alpha promoter polymorphisms in primary biliary cirrhosis.
Jones DE; Watt FE; Grove J; Newton JL; Daly AK; Gregory WL; Day CP; James OF; Bassendine MF
J Hepatol; 1999 Feb; 30(2):232-6. PubMed ID: 10068101
[TBL] [Abstract][Full Text] [Related]
19. TNF-α, TNF-β and IL-10 gene polymorphism and association with oral lichen planus risk in Saudi patients.
Al-Mohaya MA; Al-Harthi F; Arfin M; Al-Asmari A
J Appl Oral Sci; 2015; 23(3):295-301. PubMed ID: 26221924
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism in the TNF-alpha gene promoter at position -1031 is associated with increased circulating levels of TNF-alpha, myeloperoxidase and nitrotyrosine in primary Sjögren's syndrome.
Cay HF; Sezer I; Dogan S; Felek R; Aslan M
Clin Exp Rheumatol; 2012; 30(6):843-9. PubMed ID: 22703762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]